Cassava Sciences shares fall after SEC charges for misleading …
WEB4 days ago · Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission charged the biopharmaceutical company and two former executives for...
SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial …
WEB4 days ago · The SEC’s investigation found that in September 2020, Cassava disclosed manipulated data from the trial, which falsely suggested dramatic improvements in Alzheimer’s biomarkers like total tau ...
Cassava Sciences Resolves SEC Investigation
WEB5 days ago · Cassava, without admitting or denying the SEC’s allegations, agreed to pay a monetary penalty of $40 million. The Company cooperated fully with the SEC’s investigation and has implemented remedial measures.
Cassava to Pay $40 Million to SEC Over Alzheimer’s Drug Claims
WEB4 days ago · Drugmaker Cassava Sciences Inc. and two former executives agreed to pay more than $40 million to resolve US Securities and Exchange Commission claims they misled the public about the success of an Alzheimer’s drug trial.
Company misled investors on possible Alzheimer’s drug, SEC …
WEB18 hours ago · The troubled biopharma company Cassava Sciences agreed last week to pay $40 million to settle U.S. Securities and Exchange Commission (SEC) charges that it had misled investors about early clinical results for its experimental Alzheimer’s disease drug, simufilam.
SEC Announces $40 Mln Settlement With Cassava Sciences Over …
WEB4 days ago · (RTTNews) - The U.S. Securities and Exchange Commission announced Cassava Sciences Inc. (SAVA), its founder and former CEO, Remi Barbier, and its former Senior Vice President of Neuroscience,...
Cassava Sciences and former execs agree to SEC fines | STAT
WEB4 days ago · Facing charges from the Securities and Exchange Commission for misleading claims related to a controversial Alzheimer’s drug candidate, Cassava Sciences and two of the company’s former...
Cassava Sciences Resolves SEC Investigation - GlobeNewswire
WEB4 days ago · AUSTIN, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (“Cassava” or the “Company”) (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced...
PRESS RELEASES - Cassava Sciences, Inc.
WEBAUSTIN, Texas , June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences , Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for allegedly defrauding the …
Cassava's Stock Drops After It Agrees to Pay $40M to Settle SEC ...
WEB4 days ago · Cassava Sciences (SAVA) shares dropped more than 11% after the company agreed to a $40 million settlement with the Securities and Exchange Commission (SEC) over charges that it manipulated...
- Some results have been removed